PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Return
55.85%
This Quarter Return
+15.77%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$13.5B
AUM Growth
+$1.89B
(+16%)
Cap. Flow
+$513M
Cap. Flow
% of AUM
3.81%
Top 10 Holdings %
Top 10 Hldgs %
31.74%
Holding
335
New
58
Increased
110
Reduced
92
Closed
41
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$159M |
| 2 |
Johnson & Johnson
JNJ
|
$156M |
| 3 |
Chegg
CHGG
|
$85M |
| 4 |
Medtronic
MDT
|
$74.6M |
| 5 |
Humana
HUM
|
$71.3M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$135M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$123M |
| 3 |
Ciena
CIEN
|
$99.1M |
| 4 |
Advanced Micro Devices
AMD
|
$87.5M |
| 5 |
Zoom
ZM
|
$74.1M |
Sector Composition
| 1 | Technology | 35.5% |
| 2 | Healthcare | 19.85% |
| 3 | Financials | 14.53% |
| 4 | Communication Services | 13.92% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Baxter International
BAX
$12.1B
| $14.8M | 0.11% |
183,938
-641,166
| -78% | -$51.6M |
|
152
Thermo Fisher Scientific
TMO
$185B
| $14.7M | 0.11% |
33,188
-50,755
| -60% | -$22.4M |
|
153
Rockwell Automation
ROK
$38.4B
| $14.6M | 0.11% |
66,151
+3,873
| +6% | +$855K |
|
154
Alnylam Pharmaceuticals
ALNY
$59.4B
| $14.6M | 0.11% |
100,000
+25,000
| +33% | +$3.64M |
|
155
LivePerson
LPSN
$86.3M
| $14.5M | 0.11% |
278,427
+42,202
| +18% | +$2.19M |
|
156
JPMorgan Chase
JPM
$835B
| $14.3M | 0.11% |
148,168
-2,573
| -2% | -$248K |
|
157
LiveRamp
RAMP
$1.82B
| $13.4M | 0.1% |
+259,539
| New | +$13.4M |
|
158
Cognex
CGNX
$7.43B
| $13.2M | 0.1% |
203,015
-621,387
| -75% | -$40.5M |
|
159
Booking.com
BKNG
$181B
| $13.2M | 0.1% |
7,705
-4,167
| -35% | -$7.13M |
|
160
DexCom
DXCM
$31.7B
| $13.1M | 0.1% |
126,660
-69,412
| -35% | -$7.15M |
|
161
Cencora
COR
$56.7B
| $13.1M | 0.1% |
134,663
-375,337
| -74% | -$36.4M |
|
162
Wolfspeed
WOLF
$194M
| $12.3M | 0.09% |
193,004
-71,771
| -27% | -$4.57M |
|
163
Ascendis Pharma
ASND
$12B
| $11.8M | 0.09% |
76,643
+25,000
| +48% | +$3.86M |
|
|
MODV
164
DELISTED
ModivCare
MODV
| $11.1M | 0.08% |
+119,276
| New | +$11.1M |
|
165
Neurocrine Biosciences
NBIX
$13.9B
| $10.9M | 0.08% |
112,878
+23,000
| +26% | +$2.21M |
|
|
APTO
166
DELISTED
Aptose Biosciences, Inc.
APTO
| $10.8M | 0.08% |
4,012
+1,172
| +41% | +$3.16M |
|
167
Acadia Pharmaceuticals
ACAD
$4.3B
| $10.8M | 0.08% |
260,703
-734,911
| -74% | -$30.3M |
|
168
Uber
UBER
$192B
| $10.7M | 0.08% |
293,445
-1,949,926
| -87% | -$71.1M |
|
|
COUP
169
DELISTED
Coupa Software Incorporated
COUP
| $10.6M | 0.08% |
+38,506
| New | +$10.6M |
|
170
Liberty Media Series C
FWONK
$24.9B
| $10.5M | 0.08% |
+299,843
| New | +$10.5M |
|
171
eBay
EBAY
$42.5B
| $10.3M | 0.08% |
197,836
-171,430
| -46% | -$8.93M |
|
172
Arcutis Biotherapeutics
ARQT
$1.94B
| $10.3M | 0.08% |
350,000
-100,000
| -22% | -$2.93M |
|
173
MaxLinear
MXL
$1.35B
| $9.67M | 0.07% |
+416,095
| New | +$9.67M |
|
|
DCPH
174
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $8.98M | 0.07% |
175,000
+25,000
| +17% | +$1.28M |
|
175
Zentalis Pharmaceuticals
ZNTL
$128M
| $8.83M | 0.07% |
+270,000
| New | +$8.83M |
|